7:52 PM
Login form
«  August 2013  »
Entries archive

My site

Main » 2013 » August » 31
SCID screening improves medical outcomes with early detection, intervention

WALTHAM, Mass - Thursday, August 29th 2013 [ME NewsWire]

(BUSINESS WIRE) PerkinElmer, Inc., a global leader in improving the health and safety of people and the environment, today introduced the first commercially available screening test for Severe Combined Immunodeficiency (SCID). The EnLite™ Neonatal TREC System expands the newborn screening portfolio of commercially available tests and will be introduced under CE marking, for sale in select countries in Europe and the Middle East.

SCID impacts an estimated 1 in 50,000 to 1 in 100,000 newborns globally every year. The disease is a genetic disorder that can reduce lifespan but it can be treated when detected early in newborns. Treatments include bone marrow or cord blood transplant (BMT/CBT) from a family member or donor. PerkinElmer’s new SCID screening test provides a benefit over current laboratory tests by reducing steps in the workf ... Read more »
Views: 246 | Added by: africa-live | Date: 08.31.2013

ME NewsWire / BusinessWire

RESEARCH TRIANGLE PARK, N.C - Thursday, August 29th 2013

Morgan Stanley Global Healthcare Conference 2013

Quintiles CEO Tom Pike and Chief Financial Officer Kevin Gordon will present at the 2013 Morgan Stanley Global Healthcare Conference on Monday, September 9, 2013 in New York, NY at the Grand Hyatt New York.

The Quintiles presentation will begin at 9:25 a.m. EDT.  A link to live audio of the Quintiles presentation will be posted in the Event Calendar of Quintiles’ website,  An archived audio version of the presentation will be available later that day.

About Quintiles

Quintiles (NYSE:Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quint ... Read more »
Views: 266 | Added by: africa-live | Date: 08.31.2013

ME NewsWire / Business Wire

INGELHEIM, Germany - Friday, August 30th 2013

For media outside of the US, the UK & Canada only

What: Join key experts in cardiology and thrombosis for a special TweetChat (#ChatAFib), live from the ESC Congress 2013 (#ESCcongress2013) in Amsterdam, which is organised by the European Society of Cardiology

We will be discussing:

    Key issues around awareness of cardiovascular disease and thrombosis in women
    How common is antithrombotic treatment use in women versus men?
    Are women more likely than men to become disabled by an AF-related stroke?
    Management of women, cardiovascular disease and thrombosis in daily clinical practice


    Prof. Angela Maas, Professor of Cardiology for Women, UMC, St. Radboud, The Netherlands
    Dr. Yolande Appelman, Chair of the Working Group on Gender, The Ne ... Read more »
Views: 223 | Added by: uaeonlinenews | Date: 08.31.2013

Expands line-up for mobile devices

TOKYO - Friday, August 30th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Toshiba Corporation (TOKYO:6502) today announced that it has launched a small-size 1.0 x 1.0mm leadless type package, one-gate logic IC suited for mobile devices. The new product, TC7SZ32MX, will start shipping today.

In addition to the existing lead type small-size 1.0 x 1.0mm fSV package, Toshiba has developed a product with a leadless type 1.0 x 1.0 mm sMP6 package, expanding the line-up for mobile devices, such as smartphones, mobile phones, tablet devices, laptop PCs and digital cameras.

Key specifications of the new product: Part number: TC7SZ32MX 1. Operating power supply voltage range: VCC=1.65V to 5.5V 2. Output current: 24mA(min.) at VCC=3.0V 3. Super high speed operation: tpLH, tpHL = 2.4ns (typ.) at VCC=3V, CL=15pF 4. Power down protection function for 5.5V 5. Small package: sMP6 (1.0mm x 1.0mm)

Follow this link for more on this product. ht ... Read more »
Views: 203 | Added by: africa-live | Date: 08.31.2013 | Comments (0)